Identification of first-in-class paralog selective SMARCA4 degraders for treatment of haematological and prostate malignancies

  1. Home
  2. Identification of first-in-class paralog selective SMARCA4 degraders for treatment of haematological and prostate malignancies
<< Back
June 5, 2025
by admin aurigene

Identification of first-in-class paralog selective SMARCA4 degraders for treatment of haematological and prostate malignancies